The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic enzymes in Leydig cells by Matzkin, Maria Eugenia et al.
The ERK1/2 pathway regulates testosterone synthesis by
coordinately regulating the expression of steroidogenic genes in
Leydig cells
Maria Eugenia Matzkin1,2, Soichi Yamashita1, and Mario Ascoli1
1Department of Pharmacology, Carver College of Medicine, The University of Iowa, Iowa City,
Iowa
2Instituto de Biologia y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina
Abstract
Adult mice with a Leydig cell specific deletion of MAPK kinase (MEK) 1 and 2
(Mek1f/f;Mek2−/−;Cre+) mice display Leydig cell hypoplasia and hypergonadotropic
hypogonadism. We used radioimmunoassays and quantitative PCR to evaluate the function and
expression of the Leydig cell genes involved in the conversion of cholesterol to testosterone (Star,
Cyp11a1, Hsd3b6, Cyp17a1 and Hsd17b3), androgen metabolism (Srda1 and Dhrs9), and four
transcription factors (Creb1, Nr5a1, Nr4a1 and Nr0b1) that regulate the expression of
steroidogenic genes. We show that Star, Hsd3b6, Cyp17a1 and Hsd17b3 are downregulated in
Ledyig cells of adult Mek1f/f;Mek2−/−;Cre+ mice whereas Srda1 and Dhrs9 are upregulated and
Creb1, Nr5a1, Nr4a1 and Nr0b1 are unchanged or upregulated. Functionally, all the
downregulated genes but none of the upregulated genes contribute to the decrease in testosterone
synthesis in Leydig cells of adult Mek1f/f;Mek2−/−;Cre+ mice because they produce low
testosterone and dihydrotestosterone when stimulated with hCG or when incubated with
testosterone precursors such as progesterone or androstenedione.
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1.1 Introduction
Adult Leydig cells arise from postnatal stem Leydig cells several days after birth and they
proliferate and differentiate to produce testosterone, a hormone that is essential for puberty,
spermatogenesis and the maintenance of secondary sexual characteristics (Ge and Hardy,
2010; Stanley et al., 2012; Stanley et al., 2011; Teerds, 2010).
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The proliferation and differentiation of postnatal Leydig cells are dependent on luteinizing
hormone (LH) and its cognate receptor (LHR). High levels of LH or mutations of the LHR
that lead to constitutive activation result in hyperandrogenemia and Leydig cell hyperplasia
or Leydig cell adenomas, whereas LH deficiency, or mutations that inactivate the LHR
result in Leydig cell hypoplasia and hypoandrogenemia (Baker and O'Shaughnessy, 2001;
Bernichtein et al., 2008; Dufau and Tsai-Morris, 2007; Huhtaniemi, 2010; Huhtaniemi et al.,
2005; Lei et al., 2001; O'Shaughnessy et al., 1998; O'Shaughnessy et al., 2009; Rulli and
Huhtaniemi, 2005; Segaloff, 2009; Themmen, 2005; Zhang et al., 2001).
The Leydig cell ERK1/2 cascade is one of the signaling pathways activated by the agonist-
engaged LHR (Hirakawa and Ascoli, 2003; Shiraishi and Ascoli, 2006) and the involvement
of ERK1/2 on the proliferation of postnatal Leydig cells has been recently documented in
vitro (Shiraishi and Ascoli, 2007), and in vivo (Yamashita et al., 2011). For the in vivo
studies we crossed Mek1f/f;Mek2−/− and Cyp17iCre mice to generate a mouse model with a
Leydig cell specific deletion of Mek1 in the context of a global deletion of Mek2
(Mek1f/f;Mek2−/−;Cre+). The postnatal Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice lack
MEK2, express substantially reduced levels of MEK1 and normal levels of ERK1/2
(Yamashita et al., 2011). As expected from the deletion of MEK1/2, the phosphorylation of
ERK1/2 stimulated by hCG, cAMP analogs, EGF or Kit ligand is substantially reduced or
absent in the postnatal Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice (Yamashita et al., 2011).
Adult Mek1f/f;Mek2−/−;Cre+ mice develop Leydig cell hypoplasia, hypergonadotropic
hypogonadism and experience an age-dependent decrease in fertility (Yamashita et al.,
2011). Leydig cells isolated from adult Mek1f/f;Mek2−/−;Cre+ mice also displayed a reduced
ability to synthesize testosterone when incubated with hCG, a permeable cAMP analog, 22-
hydroxycholesterol or pregnenolone (Yamashita et al., 2011), thus suggesting that the
ERK1/2 cascade also regulates the steroidogenic potential of Leydig cells.
The regulation of the acute stimulation of Leydig cell steroidogenesis by the ERK1/2
cascade has been studied in some detail in vitro. All investigators agree that
pharmacological inhibitors of the ERK1/2 pathway inhibit the acute stimulation of
steroidogenesis by cAMP or trophic hormones (Evaul and Hammes, 2008; Gyles et al.,
2001; Manna et al., 2006; Manna et al., 2007; Martinelle et al., 2004) but there is no
consensus on the mechanisms involved. Some reported that this is due to an inhibition of the
expression and/or phosphorylation of StAR (Evaul and Hammes, 2008; Gyles et al., 2001;
Martinelle et al., 2004) whereas others reported that pharmacological inhibitors of ERK1/2
increased the expression and phosphorylation of StAR while inhibiting the acute stimulation
of steroiodogenesis by more complex mechanisms involving changes in the expression of a
orphan nuclear receptor (Nr0b1) and the scavenger receptor class B type 1 (Manna et al.,
2006; Manna et al., 2007).
In contrast, to the studies summarized above, the effects of the ERK1/2 cascade on the
expression of the other genes involved in androgen biosynthesis in Leydig cells has not been
explored. Here we report that Leydig cells from adult Mek1f/f;Mek2−/−;Cre+ mice have
decreased expression of many of the genes involved in testosterone synthesis and enhanced
expression of two genes coding for enzymes that metabolize androgens. Our results are the
first to document the involvement of the ERK1/2 as a coordinate regulator of the expression
of androgenic genes in Leydig cells in vivo. They also show that this decline cannot be
attributed to a decrease in the expression of several transcription factors known to
coordinately regulate the expression of steroidogenic enzymes in Leydig cells.
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1.2 Materials and Methods
1.2.1 Animals
Mek1f/f;Mek2−/−;Cre+ mice were generated as described earlier (Yamashita et al., 2011).
The mouse colony was maintained by breeding Mek1f/f;Mek2−/−;Cre− males with
Mek1f/f;Mek2−/−;Cre+ females so that littermates could be used as experimental and control
animals. Mice were housed and bred under standard conditions with food and water ad
libitum and were maintained on a 12 h dark/light cycle. Genotyping was performed using
tail genomic DNA followed by PCR amplification as described earlier (Yamashita et al.,
2011). All animal procedures were approved by the Institutional Animal Care and Use
Committee for the University of Iowa.
1.2.2 Decapsulated testes incubations
Testes were weighed, decapsulated, placed in 12 × 75 mm polystyrene tubes with 500 µl of
cold DMEM/F12 without phenol red but containing 10 mM HEPES, 50 µg/ml gentamicin,
1mg/ml BSA, pH 7.4 and incubated at 34°C for 30 min. The medium was aspirated and the
testes were then incubated for 4 h at 34°C in 1 ml of fresh medium containing vehicle only
or 100 ng/ml hCG. Alternatively they were incubated in 1 ml of fresh DMEM/F12 medium
containing 10 µl of ethanol, 10 µM androstenedione or 10 µM progesterone (each added as
10 µl aliquots of 100-fold concentrated solutions). Media were collected, centrifuged and
stored at −80°C until used for radioimmunoassay.
1.2.3 Isolation of Leydig cells
Purified Leydig cells were prepared from the testes of a single mouse by centrifuging a
mechanically-dispersed population of interstitial cells (O'Shaughnessy et al., 2002) through
a Percoll gradient (Schumacher et al., 1978). The testes from one mouse were decapsulated
and placed in a culture dish containing cold DMEM/F12 supplemented with 10 mM HEPES,
50 µg/ml gentamicin, 1 mg/ml BSA, pH 7.4. Under a dissecting microscope, tubules were
teased using fine forceps (O'Shaughnessy et al., 2002). The tubules were discarded and the
resulting cell suspension was filtered through a 70 µm Nylon cell strainer. Filtered cells were
collected by centrifugation and resuspended in 2 ml of Dulbecco’s Phosphate Buffered
Saline (D-PBS) containing 20 mM HEPES and 0.7 mg/ml BSA, pH 7.4. Leydig cells were
then purified using a discontinuous four-layer Percoll (GE Healthcare Life Sciences,
Piscataway, NJ, USA) density gradient modified from a previously published protocol
(Schumacher et al., 1978) as follows. Two ml of the interstitial cell suspension (obtained
from a single mouse, see above) were layered on top of a discontinuous density gradient
(prepared in a 15 ml conical tube) containing 3 ml of 53%, 1 ml of 40%, 4 ml of 37% and 2
ml of 20% Percoll (all prepared in the D-PBS solution with BSA listed above). The gradient
was centrifuged at 800 × g for 20 min at room temperature (Schumacher et al., 1978) and the
Leydig cells, which migrated to the 53% Percoll fraction, were diluted 2 fold with the D-
PBS solution with BSA and recovered by centrifuged at 150 × g for 15 min at room
temperature. The yield of Leydig cells/mouse was 2–3 × 105 and 5–6 × 105 for the 21 and
50 day-old mice, respectively.
For steroid assays, the Leydig cell fraction obtained from a single mouse was resuspended in
500 µl DMEM/F12 without phenol red containing 10 mM HEPES, 50 µg/ml gentamicin, 1
mg/ml BSA, pH 7.4 (Assay medium) and 250 µl aliquots were incubated in a shaking water
bath at 34C for 4h in medium containing vehicle only or 100 ng/ml hCG. Alternatively they
were incubated with vehicle only (ethanol), 10 µM androstenedione, or 10 µM progesterone.
At the end of the incubation the cells were collected by centrifugation, and the media were
collected and stored at −80°C until used for radioimmunoassay. For Western blots, Leydig
cells (or the 37% Percoll fraction containing germ cells) purified from the testes of one
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mouse were washed twice in a buffer containing 150 mM NaCl and 20 mM HEPES (pH
7.4), lysed and analyzed as described below. For real-time PCR assays (qPCR), the Leydig
or germ cells purified from the testes of one mouse were centrifuged at 1200 × g for 10 min,
resuspended in 600 µl of RLT Lysis buffer (QIAGEN Inc., Valencia, MO, USA) containing
10% of β-mercaptoethanol and stored at −80°C until RNA extractions were performed as
described in Section 1.2.6.
1.2.4 Cellular lysates and Western blot analysis
Leydig or germ cells purified from the testes of one mouse were lysed in 20–40 µl of RIPA
buffer (150 mM NaCl, 50 mM Tris, 1 mM EDTA, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 1 mM Na3VO4 and 1 mM NaF, pH 7.4)
supplemented with a commercial mixture of protease inhibitors (Roche, Indianapolis, IN,
USA). Homogenates were kept in ice for 30 min, with occasional mechanical disruption
using a pipet, followed by a centrifugation at 13,000 × g for 10 min. Supernatants were
collected and assayed for protein content using BCA protein assay kit from Bio-Rad
Laboratories, Inc. (Hercules, CA, USA). Cellular lysates were used immediately or stored at
−80°C until used. Western blots were done as described earlier (Shiraishi and Ascoli, 2007)
using 2–15 µg of lysate protein. The solutions used to block and wash the membranes, and
perform the primary and secondary antibody incubations contained either 5% milk or 1–5%
bovine serum albumin depending on the antigen being detected. The length (1–18 h) and
temperature (4°C or ambient) of the incubation and the dilutions of the primary antibodies
also varied depending on the antigen being detected. The secondary antibody dilution
(1/3,000) and length and temperature of incubation (1h at room temperature) were constant,
however. The secondary anti-mouse or anti-rabbit antibodies coupled to horseradish
peroxidase were from Bio-Rad Laboratories (catalog # 170–6515). The immune complexes
in the Western blots were eventually visualized using ECL (Pierce Chemical) and exposed
to film. The source of antibodies was as follows: VASA (Abcam # 13840), GAPDH (Cell
Signaling # 2118), and 3βHSD which was kindly donated by the late Anita Payne.
1.2.5 Radioimmunoassay
The antibodies to testosterone and progesterone were kindly donated by Dr. Gordon
Niswender. The dihydrotestosterone antibody (#20-DR14) was purchased from Fitzgerald
Industries International (Acton, Ma, USA). The radioimmunoassays were performed and
validated using conventional procedures as described earlier (Lacroix et al., 1979;
Yamashita et al., 2011). The intra-assay coefficients of variation were 1.5, 1.5 and 3% for
progesterone, testosterone and dihydrotestosterone, respectively. The inter-assay coefficients
of variation were 8.4, 10.1 and 2.1% for progesterone, testosterone and dihydrotestosterone,
respectively. Under the conditions used for the testosterone radioimmunoassays there was
no interference of the androstenedione or progesterone added to the medium.
1.2.6 RNA extraction, reverse transcription and real-time PCR
Total RNA was prepared from purified mouse Leydig cells obtained from one mouse (see
above) using the QIAGEN RNeasy mini kit (QIAGEN Inc., Valencia, MO, USA). Equal
amounts of purified Leydig cell RNA (200 ng) were reversed transcribed using dN6 random
primers (Applied Biosystems, Carlsbad, CA, USA) and M-MLV Reverse Transcriptase
(Promega, Madison, WI, USA) as described elsewhere (Frungieri et al., 2002).
Real time PCR reactions were performed in a 25 µl volume using 300 nM of each primer
and 1X iQ SYBR Green Super Mix (Bio-Rad Laboratories Inc., Hercules, CA, USA) and
fluorescence was detected on the CFX96 Real Time PCR Detection System (Bio-Rad
Laboratories Inc.). The conditions for the qPCR were optimized for each gene and the target
gene expression was normalized to an internal control, glyceraldehyde-3-phosphate
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dehydrogenase (Gapdh). The sequence for the Cyp11a1 primers was: forward =
CCCGGAGCGTTCCTT; reverse = CCAATGGGCCTCTGATAATACTG; the sequence
for the Nr5a1 primers was: forward = GCCCTGTTGGATTACACCTTG; reverse =
GTTGCCAAATGCTTGTGGTA; an the sequence for the Creb1 primers was: forward =
AGCCGGGTACTACCATTCTAC; reverse = GCAGCTTGAACAACAACTTGG. The
sequences from the other primers used were derived from the indicated references: Gapdh
(Donadeu and Ascoli, 2005), Star, Hsd3b6, Cyp17a1, Hsd17b3, Dhrs9, Srd5a1
(O'Shaughnessy et al., 2002), Nr4a1(Martin et al., 2008), Nr0b1 (Ludbrook et al., 2012) and
VASA (Kim et al., 2011). The relative expression of the different target genes in the Leydig
cells from Mek1f/f;Mek2−/−;Cre+ and Mek1f/f;Mek2−/−;Cre− mice shown in Figures 2 and 3
were calculated by the method of Pfaffl (Pfaffl, 2001). For each gene analyzed, all data are
expressed relative to the expression of the same gene in the Leydig cells of 21 day old
Mek1f/f;Mek2−/−;Cre− mice.
1.2.7 Statistical analyses
Statistical analyses were performed using Student’s t test. Statistical significance was
considered at p < 0.05.
1.3 Results
1.3.1 Effects of a Leydig cell specific deletion of Mek1 and Mek2 on steroidogenic enzyme
and transcription factor expression in postnatal Leydig cells
To analyze the expression of steroidogenic genes and the intrinsic steroidogenic capacity of
Leydig cells we purified a mechanically-dispersed population of interstitial cells
(O'Shaughnessy et al., 2002) obtained from individual 21 or 50 day-old mice using a
modified Percoll gradient protocol (Schumacher et al., 1978) as detailed in Materials and
Methods. Since the testes of Mek1f/f;Mek2−/−;Cre+ mice have fewer Leydig cells than those
of Mek1f/f;Mek2−/−;Cre− mice (see (Yamashita et al., 2011)) the use of isolated Leydig cells
is necessary because the data so obtained is normalized to the number of Leydig cells. This
normalization ensures that the functional differences observed are due to changes in the
properties of the Leydig cells rather than to changes in the number of Leydig cells/testes.
We also chose 21 and 50 day old mice because serum LH and testosterone are at prepuberal
and adult levels, respectively (O'Shaughnessy et al., 2002; Wu et al., 2010).
Figure 1 shows that we can isolate Leydig cells that are relatively free of germ cells as
judged by the Western blot detection of VASA, an abundant germ cell marker. Some Leydig
cells may contaminate the germ cell fraction but using Western blots we cannot detect an
abundant germ cell marker (VASA) in the Leydig cell fraction prepared from either 21- or
50-day old mice. VASA was also barely detectable in the Leydig cell fraction using
quantitative PCR. Under identical assay conditions, the Ct values for VASA expression
were ~35 and ~25 cycles in the Leydig cell and germ cell fractions of 50 day-old mice,
respectively. In contrast, the Ct values for all the steroidogenic enzymes shown in Figure 2
were in the range of 21–25 cycles in the Leydig cell fraction of 50 day-old mice.
An analysis of the expression of the five genes involved in the conversion of cholesterol to
testosterone in Leydig cells was next performed using cells freshly isolated and purified as
described above. The previously reported age- and LH-dependent increase in the expression
of the five genes in question (Ge and Hardy, 1998; O'Shaughnessy et al., 2002; Wu et al.,
2010) was readily apparent in the Leydig cells of Mek1f/f;Mek2−/−;Cre− mice (Figure 2A).
Importantly, the expression of these five genes is decreased in the Leydig cells of
Mek1f/f;Mek2−/−;Cre+ mice. The timing of the decreased expression varies, however. Star,
Hsd3b6 and Hsd17b3 are decreased in the Leydig cells of 21- and 50-day old mice.
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Cyp11a1 is decreased only on 21-day old mice whereas Cyp17a1 is decreased only on 50-
day old mice.
We next analyzed the expression of two Leydig cell genes involved in androgen
metabolism. Dhrs9 codes for 3α–hydroxysteroid dehydrogenase the enzyme that converts
androstenedione to androsterone and dihydrotestosterone to 3α-DIOL; Srda1 codes for 5α-
reductase, a Leydig cell enzyme that converts testosterone to dihydrotestosterone1. In
agreement with the results of others (Ge and Hardy, 1998; O'Shaughnessy et al., 2002; Wu
et al., 2010) we also found and age-related decrease in the expression of Dhrs9 and Srda1 in
the Leydig cells of Mek1f/f;Mek2−/−;Cre− mice (Figure 2B). Changes in the expression of
Dhrs9 and Srda1 in the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice are complex. Dhrs9
expression is unchanged at 21 days of age and increased at 50 days of age whereas Srda1
expression is decreased at 21 days of age and increased at 50 days of age (Fig 2B).
Last, we also measured the expression of Creb1, Nr5a1, Nr4a1 and Nr0b1 in Leydig cells
(Figure 3). Three of these transcription factors, Creb1, Nr5a1 and Nr4a1 stimulate the
expression of many of the genes needed to convert cholesterol to testosterone whereas
Nr0b1 can act as a negative regulator of the transcriptional activity of several Leydig cell
nuclear receptors (Martin and Tremblay, 2010). The expression of these transcription factors
was relatively constant from 21 to 50 days of age. The expression of Nr5a1 was the same in
both mouse genotypes at both ages but Creb1, Nr4a1 and Nr0b1 expression was increased in
the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice at both ages (Creb1 and Nr4a1) or at 21 days
of age (Nr0b1). The expression of Nr5a2, another important Leydig cell transcription factor
(Martin and Tremblay, 2010) was too low to be accurately measured.
1.3.2 Effects of a Leydig cell specific deletion of Mek1 and Mek2 on androgen synthesis
and metabolism in postnatal Leydig cells
Because of the observed changes in the expression of the genes involved in testosterone
synthesis and metabolism we also examined testosterone and dihydrotestosterone synthesis
in Leydig cells purified from 50-day old mice. As documented in Figure 4, the hCG-
provoked accumulation of testosterone and dihydrotestosterone are both decreased to about
the same extent in freshly purified Leydig cells from adult Mek1f/f;Mek2−/−;Cre+ mice. The
basal levels of testosterone are indistinguishable in the Leydig cells of the two mouse
genotypes.
The decreased levels of androgens detected in the Leydig cells of 50 day old
Mek1f/f;Mek2−/−;Cre+ mice are accompanied by an increase in the accumulation of
progesterone and pregnenolone (not shown) suggesting that the reduced expression of
Hsd3b6, Cyp17a1 and Hsd17b3 are particularly important determinants of the reduced
levels of androgens produced by Leydig cells isolated from 50 day old mice. This
conclusion is supported by the data presented in Figure 5A showing that the conversion of
progesterone to testosterone (which requires expression of Cyp17a1 and Hsd17b31), and the
conversion of androstenedione to testosterone (which requires only the expression of
Hsd17b31), are substantially lower in the purified Leydig cells from 50-day old
Mek1f/f;Mek2−/−;Cre+ mice than in those of Mek1f/f;Mek2−/−;Cre− mice. To better relate
these changes to the phenotype of the Mek1f/f;Mek2−/−;Cre+ and Mek1f/f;Mek2−/−;Cre−
mice we also measured the conversion of progesterone to testosterone and androstenedione
to testosterone in decapsulated testes instead of purified Leydig cells. The results obtained
with decapsulated testes (Figure 5B) and Leydig cells (Figure 5A) are very similar. Since the
1Figure 6, used in the Discussion, shows the pathway for androgen biosynthesis and metabolism in Leydig cells but it may be useful
to look at it while reading the Results section.
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number of Leydig cells is 2–4 times lower in the testes of Mek1f/f;Mek2−/−;Cre+ mice
(Yamashita et al., 2011) these results in Figure 5 suggest that the reduction in the expression
of Cyp17a1 and/or Hsd17b3 in the remaining Leydig cells of the testes of
Mek1f/f;Mek2−/−;Cre+ mice is quantitatively more important than the reduction in the
number of Leydig cells per testes.
1.4 Discussion
In a previous publication (Yamashita et al., 2011) we showed that primary cultures of
Leydig cells of 50-day old Mek1f/f;Mek2−/−;Cre+ mice, display a normal cAMP response to
hCG but the synthesis of testosterone is greatly decreased when stimulated with hCG, cAMP
analogs, 22-hydroxycholesterol or pregnenolone. Thus, the reduced steroidogenic capacity
of Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice cannot be explained by a decrease in the
density of the LH receptor or the ability of LH/CG to stimulate cAMP accumulation, it can
only be explained by a decrease in the expression and/or activity of one or more
steroidogenic enzymes. The experiments presented here were thus designed to identify the
steroidogenic enzymes that are decreased in the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice.
Pharmacological inhibition of the ERK1/2 cascade in vitro impairs the acute stimulation of
steroidogenesis in Leydig cells by decreasing the availability of cholesterol and/or the
transport of cholesterol to the mitochondria (Brion et al., 2011; Evaul and Hammes, 2008;
Gyles et al., 2001; Manna et al., 2006; Manna et al., 2007; Martinelle et al., 2004). The
potential involvement of the ERK1/2 pathway on the steroidogenic capacity (i.e., expression
of steroidogenic genes) of Leydig cells remains largely underexplored, however. There are
several reports on the effects of the ERK1/2 cascade on the expression and phosphorylation
of StAR in vitro but the results are conflicting (Brion et al., 2011; Evaul and Hammes, 2008;
Gyles et al., 2001; Manna et al., 2006; Manna et al., 2007; Martinelle et al., 2004).
Pharmacological inhibitors of ERK1/2 have also been reported to affect the expression or
activity of certain transcription factors that affect steroidogenic genes (Gyles et al., 2001;
Manna et al., 2006; Manna et al., 2007). With the exception of StAR (see above), however,
the effects of these inhibitors on the expression of the genes involved in androgen synthesis
in Leydig cells have not been explored. Lastly, there are also several reports on the effects of
ERK1/2 on the expression of steroidogenic genes in other tissues but these cannot always be
extrapolated to Leydig cells because they can be variable from one cell type to another
(reviewed by Manna and Stocco, 2011). Thus, the results presented herein showing that the
Leydig cells of adult Mek1f/f;Mek2−/−;Cre+ mice have decreased expression of most
androgenic genes (down arrows in Figure 6) and have reduced ability to synthesize
testosterone are novel. In fact our data show that the reduced expression of Hsd17b3 is
particularly important to the decreased androgenic capacity of the Leydig cells of adult
Mek1f/f;Mek2−/−;Cre+ mice. These cells synthesize very low levels of testosterone even
when given androstenedione as a precursor.
In contrast to the decreased expression of enzymes involved in androgen biosynthesis, the
expression of two Leydig cell androgen-metabolizing genes, Dhrs9 and Srda1 is increased in
adult Mek1f/f;Mek2−/−;Cre+ mice (up arrows in Fig 6). The increased expression of Srda1 is
unlikely to contribute to the decreased levels of testosterone in the Leydig cells of
Mek1f/f;Mek2−/−;Cre+ mice because dihydrotestosterone is also low in these cells. These
results suggest that the conversion of testosterone to dihydrotestosterone in Leydig cells is
more likely dictated by the levels of testosterone rather than by the expression of Srda1. We
restricted our studies to Srda1 because Srda2 is expressed in other cells in the testis, but not
in Leydig cells (Ge and Hardy, 1998; Pratis et al., 2000). Lastly, we cannot elaborate on the
functional significance of the increase in Dhrs9 expression because of the lack of
commercially available reagents to measure the products of the action of 3α-hydroxysteroid
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dehydrogenase, the enzyme encoded by the Dhrs9 gene. An increase in the expression of
Dhrs9 in the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice could underestimate the extent of
conversion of androstenedione to testosterone shown in Fig 5, however. If there is increased
conversion of the exogenous androstenedione to androsterone this could reduce the amount
of androstenedione available for conversion to testosterone.
The decrease expression of androgenic genes in the Leydig cells of adult
Mek1f/f;Mek2−/−;Cre+ mice suggest that the ERK1/2 cascade regulates the expression and/
or activity of a transcription factor (or factors) that coordinately regulate the expression of
these androgenic genes. Since this is a property of several transcription factors such as
Creb1, Nr4a1, Nr0b1 and Nr5a1 expressed in Leydig cells (Martin and Tremblay, 2010), we
measured their expression as well. Our data show that the decrease in androgenic gene
expression in the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice cannot be explained by a
decrease in the expression of Creb1, Nr4a1 or Nr5a1 or by an increase in the expression of
Nr0b1. It is possible that the deletion of Mek1/2 in Leydig cells could affect the activities of
CREB (the product of the Creb1 gene), SF-1, (the product of the Nr5a1 gene) or Nur77, (the
product of the Nr4a1 gene) through post-translational modifications. Indeed, acute
pharmacological inhibition of ERK1/2 impairs the cAMP-dependent phosphorylation and
transcriptional activity of SF-1 on the Star promoter in MA-10 cells (Gyles et al., 2001).
This interesting finding does not imply that the ERK1/2-mediated phosphorylation of SF-1
has the same effect on other androgenic gene promoters, however, because the effects of
SF-1 phosphorylation on its transcriptional activity are promoter-dependent (Hoivik et al.,
2010; Schimmer and White, 2010). Similarly, acute pharmacological inhibition of ERK1/2
in MA-10 has been reported to decrease the expression of Nr0b1 (Manna et al., 2007) which
acts as a negative regulator of the transcriptional activity of several nuclear receptors
(Martin and Tremblay, 2010). In contrast, our data show an increase in the expression of
Nr0b1 in the Leydig cells of Mek1f/f;Mek2−/−;Cre+ mice but only at 21 days of age. Lastly,
our studies on MA-10 cells (not presented) show that acute pharmacological inhibition of
MEK1/2 with UO126 does not affect the ability of hCG to increase the phosphorylation of
CREB. Clearly more studies are needed to identify the transcription factors that mediate the
effects of ERK1/2 on androgenic gene expression. This will require additional approaches
that are unbiased and discovery-based.
An important question in the characterization of the Mek1f/f;Mek2−/−;Cre+ mice (or other
mice with reduced androgen levels) is whether the hypoandrogenism is caused by a decrease
in the number of Leydig cells, a change in their functional properties or a combination of
both. Since Leydig cells are routinely identified using approaches that rely on the
immunological detection of markers such as Cyp17a1, 3βHSD or Cyp11a1 (Cacciola et al.,
2008; Coonce et al., 2009; Hu et al., 2010; Yamashita et al., 2011; Zhang et al., 2001) it is
difficult to know if a change in marker intensity is due to a change in the number of cells
expressing the marker, to a change in the level of expression of the marker without a change
in the actual number of cells or to a combination of these two. We have previously reported
that the density of Leydig cells/testes is decreased in the Mek1f/f;Mek2−/−;Cre+ mice when
Leydig cells are identified in histological sections of testes using Cyp11a1 as a marker
(Yamashita et al., 2011). Since we show herein that the expression of Cyp11a1 in Leydig
cells of Mek1f/f;Mek2−/−;Cre+ is reduced at some but not all ages it is possible that the
previously described reduction in Leydig cell density was influenced by a decrease in the
expression of Cyp11a1 in the Leydig cells. When we counted the total interstitial cell
population instead of the Cyp11a1 positive interstitial cells, however, the results were
similar (Yamashita et al., 2011). Thus, our conclusion that the ERK1/2 cascade is an
important determinant of Leydig cell proliferation and/or survival remains sound
(Yamashita et al., 2011).
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In summary, the experiments presented here show that the Leydig cells of
Mek1f/f;Mek2−/−;Cre+ mice have a coordinate reduction in the expression of many of the
genes that participate in androgen synthesis and that the net result of these changes is a
decrease in the capacity of Leydig cells from adult animals to synthesize androgens. We can
also conclude that the reduction of steroidogenic gene expression in Leydig cells and the
reduction in the number of Leydig cells/testis contribute to the decrease in androgen levels
in adult Mek1f/f;Mek2−/−;Cre+ mice.
1.5 Conclusions
The Leydig-cell specific deletion of Mek1/2 leads to a coordinate decrease in the expression
of Star, Hsd3b6, Cyp17a1 and Hsd17b3 and an increase in Srda1 and Dhrs9 without changes
in the expression of several transcription factors that coordinately regulate the expression of
steroidogenic genes in Leydig cells. The decrease in the expression of Hsd17b3 seems to be
particularly important to the reduced androgenic potential of Leydig cells with reduced
expression of Mek1/2 because they synthesize low amounts of testosterone even when
supplied with androstenedione, the substrate for 17βHSD3, the product of the Hsd17b3
gene.
Acknowledgments
Supported by a grant from the NIH (CA-40629) to M.A.
References
1. Baker PJ, O'Shaughnessy PJ. Role of gonadotropins in regulating numbers of Leydig and Sertoli
cells during fetal and postnatal development in mice. Reproduction. 2001; 122:227–234. [PubMed:
11467973]
2. Bernichtein S, Alevizaki M, Huhtaniemi I. Is the adrenal cortex a target for gonadotropins? Trends
in Endocrinology and Metabolism. 2008; 19:231–238. [PubMed: 18691899]
3. Brion L, Maloberti PM, Gomez NV, Poderoso C, Gorostizaga AB, Mori Sequeiros Garcia MM,
Acquier AB, Cooke M, Mendez CF, Podesta EJ, Paz C. MAPK phosphatase-1 (MKP-1) expression
is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells.
Endocrinology. 2011; 152:2665–2677. [PubMed: 21558315]
4. Cacciola G, Chioccarelli T, Mackie K, Meccariello R, Ledent C, Fasano S, Pierantoni R, Cobellis G.
Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible
involvement in adult leydig cell differentiation. Biology of reproduction. 2008; 79:758–765.
[PubMed: 18614700]
5. Coonce MM, Rabideau AC, McGee S, Smith K, Narayan P. Impact of a constitutively active
luteinizing hormone receptor on testicular gene expression and postnatal Leydig cell development.
Molecular and Cellular Endocrinology. 2009; 298:33–41. [PubMed: 19013498]
6. Donadeu FX, Ascoli M. The Differential Effects of the Gonadotropin Receptors on Aromatase
Expression in Primary Cultures of Immature Rat Granulosa Cells Are Highly Dependent on the
Density of Receptors Expressed and the Activation of the Inositol Phosphate Cascade.
Endocrinology. 2005; 146:3907–3916. [PubMed: 15919743]
7. Dufau, ML.; Tsai-Morris, CH. The luteinizing hormone receptor. In: Payne, AH.; Hardy, MP.,
editors. The Leydig cell in health and disease. Totowa, NJ: Humana Press; 2007. p. 227-252.
8. Evaul K, Hammes SR. Cross-talk between G Protein-coupled and Epidermal Growth Factor
Receptors Regulates Gonadotropin-mediated Steroidogenesis in Leydig Cells. Journal of Biological
Chemistry. 2008; 283:27525–27533. [PubMed: 18701461]
9. Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell
tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to
human fibrotic disorders. Proc Natl Acad Sci U S A. 2002; 99:15072–15077. [PubMed: 12397176]
Matzkin et al. Page 9
Mol Cell Endocrinol. Author manuscript; available in PMC 2014 May 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
10. Ge, R.; Hardy, MP. Regulation of Leydig cells during pubertal development. In: Payne, AHa.H;
MP, editors. The Leydig cell in health and disease. Totowa, New Jersey: Humana Press; 2010. p.
55-70.
11. Ge R-S, Hardy MP. Variation in the End Products of Androgen Biosynthesis and Metabolism
during Postnatal Differentiation of Rat Leydig Cells. Endocrinology. 1998; 139:3787–3795.
[PubMed: 9724031]
12. Gyles SL, Burns CJ, Whitehouse BJ, Sugden D, Marsh PJ, Persaud SJ, Jones PM. ERKs regulate
cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory
(StAR) gene. J Biol Chem. 2001; 276:34888–34895. [PubMed: 11410589]
13. Hirakawa T, Ascoli M. The lutropin/choriogonadotropin receptor (LHR)-induced phosphorylation
of the extracellular signal regulated kinases (ERKs) in Leydig cells is mediated by a protein kinase
A-dependent activation of Ras. Molecular Endocrinology. 2003; 17:2189–2200. [PubMed:
12920236]
14. Hoivik EA, Lewis AE, Aumo L, Bakke M. Molecular aspects of steroidogenic factor 1 (SF-1). Mol
Cell Endocrinol. 2010; 315:27–39. [PubMed: 19616058]
15. Hu G-X, Lin H, Chen G-R, Chen B-B, Lian Q-Q, Hardy DO, Zirkin BR, Ge R-S. Deletion of the
Igf1 Gene: Suppressive Effects on Adult Leydig Cell Development. J Androl. 2010; 31:379–387.
[PubMed: 20203337]
16. Huhtaniemi I. Are gonadotrophins tumorigenic--A critical review of clinical and experimental
data. Molecular and Cellular Endocrinology. 2010; 329:56–61. [PubMed: 20471448]
17. Huhtaniemi IT, Rullin S, Ahtiainen P, Poutanen M. Multiple sites of tumorigenesis in transgenic
mice overproducing hCG. Molecular and Cellular Endocrinology. 2005; 234:117–126. [PubMed:
15836960]
18. Kim B, Kim Y, Sakuma R, Hui CC, Ruther U, Jorgensen JS. Primordial germ cell proliferation is
impaired in Fused Toes mutant embryos. Dev Biol. 2011; 349:417–426. [PubMed: 20969841]
19. Lacroix A, Ascoli M, Puett D, McKenna TJ. Steroidogenesis in hCG-responsive Leydig cell tumor
variants. Journal of Steroid Biochemistry. 1979; 10:669–675. [PubMed: 314019]
20. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao CV. Targeted Disruption of Luteinizing
Hormone/Human Chorionic Gonadotropin Receptor Gene. Molecular Endocrinology. 2001;
15:184–200. [PubMed: 11145749]
21. Ludbrook LM, Bernard P, Bagheri-Fam S, Ryan J, Sekido R, Wilhelm D, Lovell-Badge R, Harley
VR. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by
inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
Endocrinology. 2012; 153:1948–1958. [PubMed: 22294746]
22. Manna PR, Chandrala SP, King SR, Jo Y, Counis R, Huhtaniemi IT, Stocco DM. Molecular
mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute
regulatory protein in mouse leydig cells. Mol Endocrinol. 2006; 20:362–378. [PubMed: 16166197]
23. Manna PR, Jo Y, Stocco DM. Regulation of Leydig cell steroidogenesis by extracellular signal-
regulated kinase 1/2: role of protein kinase A and protein kinase C signaling. J Endocrinol. 2007;
193:53–63. [PubMed: 17400803]
24. Manna PR, Stocco DM. The role of specific mitogen-activated protein kinase signaling cascades in
the regulation of steroidogenesis. Journal of signal transduction. 2011; 2011:821615. [PubMed:
21637381]
25. Martin LJ, Boucher N, Brousseau C, Tremblay JJ. The orphan nuclear receptor NUR77 regulates
hormone-induced StAR transcription in Leydig cells through cooperation with Ca2+/calmodulin-
dependent protein kinase I. Mol Endocrinol. 2008; 22:2021–2037. [PubMed: 18599618]
26. Martin LJ, Tremblay JJ. Nuclear Receptors in Leydig Cell Gene Expression and Function. Biology
of Reproduction. 2010; 83:3–14. [PubMed: 20375256]
27. Martinelle N, Holst M, Soder O, Svechnikov K. Extracellular Signal-Regulated Kinases Are
Involved in the Acute Activation of Steroidogenesis in Immature Rat Leydig Cells by Human
Chorionic Gonadotropin. Endocrinology. 2004; 145:4629–4634. [PubMed: 15242988]
28. O'Shaughnessy PJ, Baker P, Sohnius U, Haavisto A-M, Charlton HM, Huhtaniemi I. Fetal
Development of Leydig Cell Activity in the Mouse Is Independent of Pituitary Gonadotroph
Function. Endocrinology. 1998; 139:1141–1146. [PubMed: 9492048]
Matzkin et al. Page 10
Mol Cell Endocrinol. Author manuscript; available in PMC 2014 May 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
29. O'Shaughnessy PJ, Morris ID, Huhtaniemi I, Baker PJ, Abel MH. Role of androgen and
gonadotrophins in the development and function of the Sertoli cells and Leydig cells: Data from
mutant and genetically modified mice. Molecular and Cellular Endocrinology. 2009; 306:2–8.
[PubMed: 19059463]
30. O'Shaughnessy PJ, Willerton L, Baker PJ. Changes in Leydig Cell Gene Expression During
Development in the Mouse. Biology of Reproduction. 2002; 66:966–975. [PubMed: 11906915]
31. Payne, AH. Steroidogenic enzymes in Leydig cells. In: Payne, AH.; Hardy, MH., editors. The
Leydig cell in Health and Disease. Totowa, NJ: 2007. p. 157-171.
32. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic
Acids Res. 2001; 29:e45. [PubMed: 11328886]
33. Pratis K, O'Donnell L, Ooi GT, McLachlan RI, Robertson DM. Enzyme assay for 5alpha-reductase
type 2 activity in the presence of 5alpha-reductase type 1 activity in rat testis. The Journal of
steroid biochemistry and molecular biology. 2000; 75:75–82. [PubMed: 11179911]
34. Rulli SB, Huhtaniemi I. What have gonadotrophin overexpressing transgenic mice taught us about
gonadal function? Reproduction. 2005; 130:283–291. [PubMed: 16123235]
35. Schimmer BP, White PC. Minireview: steroidogenic factor 1: its roles in differentiation,
development, and disease. Mol Endocrinol. 2010; 24:1322–1337. [PubMed: 20203099]
36. Schumacher M, Schäfer G, Holstein AF, Hilz H. Rapid isolation of mouse Leydig cells by
centrifugation in percoll density gradients with complete retention of morphological and
biochemical integrity. FEBS Letters. 1978; 91:333–338. [PubMed: 210046]
37. Segaloff, DL. Diseases Associated with Mutations of the Human Lutropin Receptor. In: Ya-Xiong,
T., editor. Progress in Molecular Biology and Translational Science. Academic Press; 2009. p.
97-114.
38. Shiraishi K, Ascoli M. Activation of the lutropin/choriogonadotropin receptor (LHR) in MA-10
cells stimulates tyrosine kinase cascades that activate Ras and the extracellular signal regulated
kinases (ERK1/2). Endocrinology. 2006; 147:3419–3427. [PubMed: 16614081]
39. Shiraishi K, Ascoli M. Lutropin/choriogonadotropin (LH/CG) stimulate the proliferation of
primary cultures of rat Leydig cells through a pathway that involves activation of the ERK1/2
cascade. Endocrinology. 2007; 148:3214–3225. [PubMed: 17412805]
40. Stanley E, Lin CY, Jin S, Liu J, Sottas CM, Ge R, Zirkin BR, Chen H. Identification, Proliferation,
and Differentiation of Adult Leydig Stem Cells. Endocrinology. 2012; 153:5002–5010. [PubMed:
22865373]
41. Stanley EL, Johnston DS, Fan J, Papadopoulos V, Chen H, Ge RS, Zirkin BR, Jelinsky SA. Stem
Leydig cell differentiation: gene expression during development of the adult rat population of
Leydig cells. Biology of reproduction. 2011; 85:1161–1166. [PubMed: 21832170]
42. Teerds, KaR; E. Dynamics of Leydig cell regeneration after EDS: a model for postnatal Leydig
cell development. In: Payne, AH.; Hardy, MP., editors. The Leydig cell in health and disease.
Totowa, New Jersey: Humana Press; 2010. p. 91-116.
43. Themmen APN. An update of the pathophysiology of human gonadotrophin subunit and receptor
gene mutations and polymorphisms. Reproduction. 2005; 130:263–274. [PubMed: 16123233]
44. Wu X, Arumugam R, Zhang N, Lee M. Androgen profiles during pubertal Leydig cell
development in the mouse. Reproduction. 2010; 140:113–121. [PubMed: 20453159]
45. Yamashita S, Tai P, Charron J, Ko C, Ascoli M. The Leydig Cell MEK/ERK Pathway Is Critical
for Maintaining a Functional Population of Adult Leydig Cells and for Fertility. Molecular
Endocrinology. 2011; 25:1211–1222. [PubMed: 21527500]
46. Zhang F-P, Poutanen M, Wilbertz J, Huhtaniemi I. Normal Prenatal but Arrested Postnatal Sexual
Development of Luteinizing Hormone Receptor Knockout (LuRKO) Mice. Molecular
Endocrinology. 2001; 15:172–183. [PubMed: 11145748]
Matzkin et al. Page 11
Mol Cell Endocrinol. Author manuscript; available in PMC 2014 May 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Highlights
• Deletion of Mek1/2 decreases expression of androgenic genes in Leydig cells.
• Deletion of Mek1/2 increases expression of androgen metabolism genes in
Leydig cells.
• Deletion of Mek1/2 decreases androgen synthesis in Leydig cells.
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Figure 1. A germ cell-free Leydig cell fraction can be readily obtained from the testes of a single
mouse by Percoll gradient centrifugation
Mechanically dispersed interstitial cells from the testes of individual Mek1f/f;Mek2−/−;Cre−
mice of the indicated ages were fractionated on Percoll gradients as described in Materials
and Methods. The cells migrating into the 37% or 53% Percoll solutions were collected,
lysed and analyzed for VASA (a germ cell marker), 3βHSD (a Leydig cell marker) or
GAPDH (loading control) using Western blots. DMRT-1, a marker for Sertoli cells and
spermatogonia was also undetectable in the 53% Percoll fraction (data not shown). The
results of a representative experiment are shown.
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Figure 2. Expression of genes involved in testosterone biosynthesis and metabolism in Leydig
cells of Mek1f/f;Mek2−/−;Cre− and Mek1f/f;Mek2−/−;Cre+ mice
Gene expression was measured by real time PCR using equal amounts of RNA isolated from
freshly purified Leydig cells (see Figure 1) obtained from the testes of individual mice of the
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indicated genotype and age as detailed in Materials and Methods. All data are corrected for
the expression of Gapdh and expressed relative to the expression of the indicated genes in
the Leydig cells of the 21 day old Mek1f/f;Mek2−/−;Cre− mice. (A) Enzymes involved in
testosterone synthesis; (B) enzymes involved in testosterone metabolism. Results are the
mean ± SEM of at least 5 mice. Asterisks indicate statistically different results (p < 0.05)
between the two genotypes of age-matched mice
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Figure 3. Expression of selected transcription factors in Leydig cells of Mek1f/f;Mek2−/−;Cre−
and Mek1f/f;Mek2−/−;Cre+ mice
Gene expression was measured by real time PCR using equal amounts of RNA isolated from
freshly purified Leydig cells (see Figure 1) obtained from the testes of individual mice of the
indicated genotype and age as detailed in Materials and Methods. All data are corrected for
the expression of Gapdh and expressed relative to the expression of the indicated genes in
the Leydig cells of the 21 day old Mek1f/f;Mek2−/−;Cre− mice. Results are the mean ± SEM
of at least 5 mice. Asterisks indicate statistically different results (p < 0.05) between the two
genotypes of age-matched mice.
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Figure 4. Testosterone and dihydrotestosterone synthesis in Leydig cells of
Mek1f/f;Mek2−/−;Cre− and Mek1f/f;Mek2−/−;Cre+ mice
Testosterone and dihydrotestosterone levels were measured in purified Leydig cells from 50
day old mice of the indicated genotype incubated without or with 100 ng/ml hCG for 4h at
34C. Results are the mean ± SEM of 3–4 mice. Asterisks indicate statistically different
results (p < 0.05) between the two genotypes.
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Figure 5. Testosterone synthesis in decapsulated testes or Leydig cells of Mek1f/f;Mek2−/−;Cre−
and Mek1f/f;Mek2−/−;Cre+ mice incubated with testosterone precursors
Testosterone levels were measured in purified Leydig cells or decasulated testes from 50 day
old mice of the indicated genotype incubated without or with 10 µM progesterone or
androstenedione for 4h at 34C. Results are the mean ± SEM of at least 5 mice. Asterisks
indicate statistically different results (p < 0.05) between the two genotypes.
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Figure 6. Pathways for testosterone synthesis and metabolism in Leydig cells
Gene symbols are shown for the protein involved in the transport of cholesterol to the inner
mitochondrial membrane (Star), the four enzymes that convert cholesterol to testosterone
(Cyp11a1, Hsd3b6, Cyp17a1, and Hsd17b3) and the two enzymes that metabolize
androgens, Srda1 and Dhrs9 in Leydig cells (Payne, 2007). Only the Δ4 pathway for
testosterone synthesis is shown because this is the predominant pathway in murine Leydig
cells (Payne, 2007). The up and down white arrows highlight genes that are up or down
regulated in the Leydig cells of 50 day-old Mek1f/f;Mek2−/−;Cre+ mice.
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